Thu, 5 Nov
Dr. Agarwals Health Care
Q2 FY27 revenue ₹655 Cr (+31.4% YoY) and PAT ₹57 Cr (+55.8%), network-led growth; India EBITDA margin flat near 28%.
Summary ready
Earnings calls
Dr. Agarwals Health Care concalls
Every Dr. Agarwals Health Care earnings call we streamed: the live audio and our summary of what management said.
Calls
Q2 FY27: key takeaways
Call page →Q2 FY27 revenue ₹655 Cr (+31.4% YoY) and PAT ₹57 Cr (+55.8%), network-led growth; India EBITDA margin flat near 28%.
Outlook
Capex raised to ₹500 Cr; 65 facilities in FY27 (55 surgical), 26 in H2. No revenue or PAT growth guidance given.
Earlier call summaries
All →
13:44 IST
BSE
Earnings Call
Dr. Agarwals Health Care Earnings Call: Key Takeaways
Dr. Agarwal’s reported strong FY26 performance, crossing INR 2,000cr revenue milestone with significant network expansion and EBITDA margin improvement to 28.9%.
18:21 IST
BSE
Earnings Call
Dr. Agarwals Health Care Earnings Call: Key Takeaways
Dr. Agarwals reported 21% income growth in FY26, driven by aggressive network expansion (57 new facilities) and clinical excellence.
Dr. Agarwals Health Care Ltd: key numbers
- Share price
- ₹511.70
- Market cap
- ₹16,222 Cr
- Revenue (annual)
- ₹2,080 Cr
- Net profit (annual)
- ₹133.2 Cr
- P/E (TTM)
- 109.3×Sector 54.5×
- Promoter holding
- 32.33%-0.01% QoQ
- FII holding
- 49.56%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.